1. Academic Validation
  2. Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane

Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane

  • Eur J Med Chem. 2024 Nov 26:283:117101. doi: 10.1016/j.ejmech.2024.117101.
Xiaolin Lu 1 Xianghan Xu 2 Yushi Ding 3 Xin Gong 4 Liqin Ming 4 Xingyang Dai 5 Congying Gu 4 Jiayi Wang 4 Jiaqi Zhao 2 Mengkang Gao 4 Hao Yin 4 Zhi Wang 4 Xiaoming Wang 5 Liping Wang 5 Dayong Zhang 6 Menghan Zhang 7 Jinhu Huang 8
Affiliations

Affiliations

  • 1 School of Science, China Pharmaceutical University, Nanjing, 211198, China; School of Pharmacy, Shanxi Medical University, Taiyuan, 030001, China.
  • 2 MOE Joint International Research Laboratory of Animal Health and Food Safety, Risk Assessment Center of Veterinary Drug Residue and Antimicrobial Resistance, Center for Veterinary Drug Research and Evaluation, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China; Sanya Institute of Nanjing Agricultural University, Nanjing Agricultural University, Sanya, 572025, China.
  • 3 State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, China.
  • 4 School of Science, China Pharmaceutical University, Nanjing, 211198, China.
  • 5 MOE Joint International Research Laboratory of Animal Health and Food Safety, Risk Assessment Center of Veterinary Drug Residue and Antimicrobial Resistance, Center for Veterinary Drug Research and Evaluation, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China.
  • 6 School of Science, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: cpuzdy@163.com.
  • 7 School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: 1520220087@cpu.edu.cn.
  • 8 MOE Joint International Research Laboratory of Animal Health and Food Safety, Risk Assessment Center of Veterinary Drug Residue and Antimicrobial Resistance, Center for Veterinary Drug Research and Evaluation, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China; Sanya Institute of Nanjing Agricultural University, Nanjing Agricultural University, Sanya, 572025, China. Electronic address: jhuang@njau.edu.cn.
Abstract

Increasing antimicrobial resistance underscores the urgent need for new Antibiotics with unique mechanisms. Type I signal peptidase (SPase I) is crucial for Bacterial survival and a promising target for Antibiotics. Herein we designed and synthesized innovative tetrahydroacridine-9-carboxylic acid derivatives by optimizing the initial hit compound SP11 based on virtual screening. Structure-activity relationship (SAR) studies and bioactivity assessments identified compound C09 as a standout, showing excellent in vitro antimicrobial activity against MRSA and Other multidrug-resistant Gram-positive pathogens. C09 targets SPase I with a favorable affinity, disrupts Bacterial cell membranes, and eradicates biofilms, reducing resistance risk. In vivo tests in a murine MRSA skin Infection model demonstrated significant efficacy. Additionally, C09 has good liver microsome metabolic stability, safe hemolytic activity and mammalian cytotoxicity, as well as a good in vivo safety profile. Overall, our findings highlight the potential of tetrahydroacridine-9-carboxylic acid derivatives as a novel class of Antibiotics against multidrug-resistant Gram-positive bacteria.

Keywords

Antimicrobial resistance; Bacterial membrane; Novel antibiotics; SPase I; Tetrahydroacridine derivatives.

Figures
Products